Ongoing research offers new promise for patients with metastasized, castration-resistant prostate cancer.
A new study may help men make more informed decisions about prostate cancer treatment.
A new study could lead to better tailoring of treatments to individual patients.
Urine-Based Prostate Cancer Test Honored for Innovation
A non-invasive prostate cancer test developed by miR Scientific, LLC, can definitively detect the disease’s presence — a major improvement on standard-of-care screening, which produces significant numbers of false-positive and false-...
Convenience, fewer missed appointments and lower insurance costs benefit patients and doctors. Having access to patients’ medical records, private on-camera communication, and reducing unnecessary in-office and ER visits are a few reasons telemedicine continues to grow in popularity.
Results presented at the American Association for Cancer Research (AACR) Annual Meeting 2019 show prostate cancer incidence and mortality rates are stabilizing or decreasing in many countries around the world.
Emerging studies are exploring the relationship between DNA and male infertility.
More Aggressive Combination Therapy Offers Survival Advantage for High-Risk Prostate Cancer Patients
Men with locally or regionally advanced prostate cancer who receive radical prostatectomy followed by radiation therapy live longer than those who receive radiation therapy plus androgen deprivation therapy (ADT), according to a recent study.
Testosterone use decreased dramatically from 2013 to 2016, amid an outpouring of study results and FDA alerts regarding associations between testosterone products and risk of stroke, heart attack and/or death.
Five men with spinal cord injuries that impaired the ability to voluntarily urinate gained improved bladder control as well as average quality-of-life improvement of 60 percent after lower-spinal-cord stimulation, according to a study in Scientific Reports.
- 1 of 3
- next ›